Long hauler symptoms and potential treatments (part 1); 11,243 viewsApr 12, 2021 - https://www.youtube.com/watch?v=g1xtb6zJ8LU
Ivermectin - Long hauler symptoms and potential treatments (part 2)- https://www.youtube.com/watch?v=j8sc8u-j98o
173,674 views, Apr 19, 2021
Health & Wellness Center
A great resource for long haulers:
— Dr. Mark White Gateway Health and
Wellness Center Columbus, OH www.gateway.healthcare Follow us on Facebook at: https://www.facebook.com/pages/Gatewa...
- ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. - https://clinicaltrials.gov
- NIH COVID-19 Treatment Guidelines - https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ - -
- The FDA-approved
drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- - https://www.sciencedirect.com/science/article/pii/S0166354220302011 -
- Prophylactic Ivermectin
in COVID-19 Contacts - https://clinicaltrials.gov/ct2/show/NCT04422561
- Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic - https://www.researchsquare.com/article/rs-100956/v2
- Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 - https://journal.chestnet.org/article/S0012-3692(20)34898-4/fulltext
Ivermectin for COVID-19 in Peru - Abstract
Introduction. On May 8, 2020, Peru’s Ministry of Health approved ivermectin (IVM), a drug of Nobel Prize-honored distinction,
for inpatient and outpatient treatment of COVID-19. As IVM treatments proceeded in that nation of 33 million residents, excess deaths decreased 14-fold over four months through December 1, 2020, consistent with clinical benefits of IVM for COVID-19 found in
several RCTs. But after IVM use was sharply restricted under a new president, excess deaths then increased 13-fold. Methods. To evaluate possible IVM treatment effects suggested by these aggregate trends, excess deaths were analyzed by state for ages ≥
60 in Peru’s 25 states. To identify potential confounding factors, Google mobility data, population densities, SARS-CoV-2 genetic variations and seropositivity rates were also examined. Results. The 25 states of Peru were grouped by extent of IVM distributions:
maximal (mass IVM distributions through operation MOT, a broadside effort led by the army); medium (locally managed IVM distributions); and minimal (restrictive policies in one state, Lima). The mean reduction in excess deaths 30 days after peak deaths was
74% for the maximal IVM distribution group, 53% for the medium group and 25% for Lima. Reduction of excess deaths is correlated with extent of IVM distribution by state with a p value of 0.002 using the Kendall τb test. Conclusion. Mass treatments with
IVM, a drug safely used in 3.7 billion doses worldwide since 1987, most likely caused the 14-fold reductions in excess deaths in Peru, prior to their 13-fold increase under reversed IVM policy. This strongly suggests that IVM treatments can likewise effectively
complement immunizations to help eradicate COVID-19. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, possibly yielding full efficacy against emerging viral mutant strains.
Edgy Edge -Hope everyone is doing well during this pandemic. A new study came out talking about the potential use and efficacy of ivermectin to treat coronavirus (Covid-19). In this video, I highlight the main points of the study
and give my take on it's potential use as a treatment for coronavirus.
Link to the study: https://www.naturalnews.com/2021-08-17-vaxxed-to-death-alarming-study-confirms-vaxxers-will-face-catastrophic-antibody-dependent-enhancement-injuries-and-deaths.html
Ivermectin is an FDA approved medication that is used as an anti-parasitic. Ivermectin also has reported antiviral activity and is theorized to work against coronavirus. It's proposed mechanism of action is preventing the coronavirus protein
from entering the nucleus of your cells.